Thrombospondin-1, PECAM-1, and regulation of angiogenesis

Histology and Histopathology

Volumn 14, Issue 1, 1999, Pages 285-294

  Sheibani, N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD31; Endothelial cells; Thrombospondins

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; CD36 ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; INTEGRIN; MESSENGER RNA; PROCOLLAGEN; STROMELYSIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VIRUS MIDDLE T ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; CARCINOGENESIS; ENDOTHELIUM CELL; GENE EXPRESSION; HEMANGIOMA; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; POLYOMA VIRUS; REVIEW; VIRUS CELL TRANSFORMATION;

ANIMALS; ANTIGENS, CD31; ENDOTHELIUM, VASCULAR; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; THROMBOSPONDIN 1;

EID: 0032968510     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Adams J.C., Tucker R.P. and Lawler J. (1995). The Thrombospondin gene family. R.G. Landes Company. Austin, TX.
2. Asch A.S. (1993). The role of CD36 as thrombospondin receptor. In: Thrombospondin. Lahav J. (ed). CRC Press, Inc. Boca Raton, FL. pp 65-275.
3. Asch A.S., Silbiger S., Heimer E. and Nachman R.L. (1992). Thrombo-spondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 182, 1208-1217.
4. Asch A.S., Liu I., Briccetti P.M., Barnwell J.W., Kwakye-Berko F., Dokun A., Goldberger J. and Pernambuco M. (1993). Analysis of CD36 binding domains: Ligand specificity controlled by Dephosphorylation of an ectodomain. Science 262, 1436-1440.
5. Baenziger N.L., Brodie G.N. and Majerus P.W. (1971). A thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. USA 68, 240-243.